Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

85.40
Delayed Data
As of Nov 26
 -4.17 / -4.66%
Today’s Change
71.59
Today|||52-Week Range
92.57
-2.61%
Year-to-Date

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Biomarin Pharmaceutical Inc have a median target of 112.00, with a high estimate of 173.00 and a low estimate of 89.00. The median estimate represents a +31.15% increase from the last price of 85.40.

Analyst Recommendations

The current consensus among 22 polled investment analysts is to Buy stock in Biomarin Pharmaceutical Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.35
Sales
$443.0M
Reporting Date
Feb 24

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -75.38%
 
 
 
 
 
 
Growthannually -107.84%
 
 
 
 
 
 

Sales

Growthquarterly 8.39%
 
 
 
 
 
 
Growthannually -0.91%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.